@Hero76 tomorrow when?

private placement not yet complete. must wait patiently

breakout is imminent. hold your seatbelt. it is going up to 21 sen

looks good. undervalue with long term prospect especially with the strategic partnership with Huawei

kanger venture into shipping?

i just collect .405. good potential and good price

https://www.tradingview.com/chart/ZELAN/K24YIUrc-LONG-On-its-way-to-test-next-Resistance-at-15/

something big coming?

take over at pp price

GETS is buying Latexx Partners from Semperit?

2nd wave just started

UNCONDITIONAL MANDATORY TAKE-OVER OFFER BY EKOVEST BERHAD ("OFFEROR") THROUGH RHB INVESTMENT BANK BERHAD AS PRINCIPAL ADVISER AND ASTRAMINA ADVISORY SDN BHD AS FINANCIAL ADVISER TO ACQUIRE ALL THE REMAINING SECURITIES IN PLS PLANTATIONS BERHAD NOT ALREADY HELD BY THE OFFEROR FOR A CASH OFFER PRICE OF RM0.95 PER SHARE AND RM0.15 PER WARRANT ("OFFER")

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3106622

no more below 30c after this

any news on AT buying Bidor Multisafe? If yes, then good acceleration to glove industry.

SIS at 26 sen, this is cheaper to buy

https://www.atsys.com.my/wp-content/uploads/2020/09/EGM-Presentation.pdf

@oskchoon The annual turn over is RM 860 million which is 40 times the present TR, so the actual price should be RM 0.06 multiply by 40, the 2021 share price estimates to be at least RM 1.00 and above...

yes it should be Rm2 worth. Look at GETS, already rm3.

today will break 30 sen

SIS is at 24 sen. So, AT is foreseeing the price should be at least worth more than that

"This focus is expected to enable its glove manufacturing plant to be established in a mere five months period, as compared to the average period of one-year which is typically required for a glove manufacturing facility to be completed and commissioned,” the firm's statement read.

"Despite the setback in relation to the proposed acquisition of Pearl Glove, the group said we remain committed to accelerate the completion of our glove manufacturing plant in Perak, through which we target to see the delivery of our first batch of nitrile gloves by the end of this year. This would enable revenue contribution from the new glove business in the current financial year of 2021 (FY21),” said AT Systematization's managing director Choong Lee Aun.

Choong said the firm's investment and growth strategy are supported by the continued strong demand for gloves, adding that the company has received "overwhelming response and enquiries for orders from foreign and local buyers, even before the start of production".

"On top of that, ATS also provided earnings guidance on the new venture. The company expects the rubber glove business to contribute RM860 million in annual turnover, which is over 40 times the RM20 million achieved in its financial year ended March 31, 2020 (FY20)."

On Oct 28, the company said it expected to reach an annual production capacity of up to 2.6 billion pieces of medical-grade nitrile gloves by June 2021, based on the assumption that its production lines run 24 hours per day and 30 days per month.

ATS is in the midst of building its glove manufacturing facility in Perak.

On top of that, ATS also provided earnings guidance on the new venture. The company expects the rubber glove business to contribute RM860 million in annual turnover, which is over 40 times the RM20 million achieved in its financial year ended March 31, 2020 (FY20).

uncle say GETS already rm2, AT should follow

uncle say AT should be Rm1 at least

"ATS also provided earnings guidance on the new venture. The company expects the rubber glove business to contribute RM860 million in annual turnover, which is over 40 times the RM20 million achieved in its financial year ended March 31, 2020 (FY20)."

will go to 1 ringgit in 2 weeks time. hold tightly

check AT price during Oct 2013. This is just the beginning.

will follow GETS

@Roroho00 read carefully. it's the ultra cold condition. Sinopharm vaccine doesnt have such limitation

follow KSTAR soon

https://klse.i3investor.com/blogs/damiantreez/2020-11-10-story-h1535718043-UAE_Prime_Minister_Receives_Sinopharm_COVID_19_Vaccine.jsp

Yes, and this will prove Sinopharm is taking it seriously. Soon it will be available to the masses

free warrant. just collect

soon will catch up to Solution 90c

Kanger is laggard. buy now at 20c while you still can

sinovac and sinopharm are 2 different companies

https://www.thestar.com.my/business/business-news/2020/10/14/kanger-to-raise-rm6888m-with-vaccine-in-mind

China National Pharmaceutical Group (Sinopharm), one of several Chinese firms developing coronavirus vaccines, said it may have the capacity to produce more than 1 billion doses in 2021

i believe Sinopharm vaccine will be the first to be distributed to mass worldwide including Malaysia. Kanger will definitely gain from this

https://klse.i3investor.com/blogs/damiantreez/2020-11-10-story-h1535718043-UAE_Prime_Minister_Receives_Sinopharm_COVID_19_Vaccine.jsp

56,000 people tested vs Pfitzer 94 people testing. Sinopharm vaccine is the real deal.

No infections among 56,000 people who traveled abroad after receiving Sinopharm-developed COVID-19 vaccine: developer

https://www.globaltimes.cn/content/1206008.shtml

hold tight. TP RM2 by next year

Free warrants

healthcare + glove. LKL is super stock and will benefit even more under Budget 2021. Congratulations!

https://www.theedgemarkets.com/article/lkl-and-systematization-ink-deal-market-and-distribute-gloves

i dont understand people who waste time just to post something negative without fact or basis. just talk shit

https://codeblue.galencentre.org/2020/11/02/budget-2021-time-to-over-invest-in-health-malaysian-health-coalition/

today's BUDGET will focus more on healthcare. Expect LKL to benefit a lot